Lackluster Trading In Biotech:Sell-Off Continues In Smaller Caps
Markets stabilized today with major indices up in the 0.4% range. Despite some weakness in meteoric biopharma stocks the healthcare sector is catching bids. Unloved and unwanted Johnson and Johnson(JNJ $61.87) is trying to shake off product quality issues up 2.33%, raising its 2011 guidance...
Biotech Rally Ends With S&P Negative Outlook;But Amarin (AMRN) Soars
Even the biotech bulls bailed today on the double whammy of concern about Europe's debt crisis and the S&P echoing the Tea Party refrain about the U.S. budget deficit and need for fiscal reform. As of mid-day trading both the S&P 500 and the NASDAQ is down are down 1.5% . Biotechnology...
Biotech Stocks Roll Merrily Along Up 1%+
Drug and Biotechnology Stocks Up Across the Spectrum Its "groundhog day" in biotech world. Apparently money that has come out of tech stocks and money markets is going into healthcare stocks. In case you missed it even large cap drug stocks which have lagged the S&P YTD are in a rally mode....
Biggest Biotech Trends
This was published today on www.InvestorUprising.com. Biotech stocks are up 10% YTD. Investor Uprising - Rod Raynovich - The Biggest Biotech Trends
Biotech Sector Outperforming Within NASDAQ: Dendreon(DNDN),Idenix(IDIX) and Viropharma(VPHM) Soar
Biotech stocks are up again today ignoring the overall weakness in tech stocks. Among the notable movers today are: Dendreon (DNDN $41.15) broke out above 40 up 5.5% on heavy volume with high expectations for the May 2 Conference call and presentation of data at ASCO in June. Idenix (IDIX...